COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,708 Articles (22,913 medRxiv, 8,795 bioRxiv)

Most recent first Previous |  Page 1549: Articles 15481-15490  | Next

COVID-19 vaccination hesitancy model: The impact of vaccine education on controlling the outbreak in the United States
Oduro, B., Miloua, A., Apenteng, O. O., Osei, P. P.
10.1101/2021.05.21.21257612 — Posted: 2021-05-25
Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary
Goodwin, R., Ben-Ezra, M., Takahashi, M., Nguyen Luu, L. A., Borsfay, K., Kovacs, M., Hou, W. K., Hamama-Raz, Y., Levin, Y.
10.1101/2021.05.24.21257465 — Posted: 2021-05-25
ABO blood group is involved in the quality of the specific immune response
Gil-Manso, S., Miguens Blanco, I., Motyka, B., Halpin, A., Lopez-Estaban, R., Perez-Fernandez, V. A., Carbonell-Munoz, D., Lopez-Fernandez, L. A., west, L. J., Correa-Rocha, R., Pion, M.
10.1101/2021.05.23.445114 — Posted: 2021-05-25
Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: a 14-month observational study using surveillance data
Yassi, A., Grant, J. M., Lockhart, K., Barker, S., Sprague, S., Okpani, A. I., Wong, T., Daly, P., Henderson, W., Lubin, S., Kim Sing, C.
10.1101/2021.05.21.21257600 — Posted: 2021-05-25 Discussion: Offsite
A Phenomenological Analysis of COVID-19
Macchiavelli, A. O., Marti, G. V., Marti, J. G.
10.1101/2021.05.23.21249471 — Posted: 2021-05-25
Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
Roman, Y. M., Burela, P. A., Pasupuleti, V., Piscoya, A., Vidal, J. E., Hernandez, A. V.
10.1101/2021.05.21.21257595 — Posted: 2021-05-25 Discussion: Onsite | Offsite
SARS-CoV-2 spike protein unlikely to bind to integrins via the Arg-Gly-Asp (RGD) motif of the Receptor Binding Domain: evidence from structural analysis and microscale accelerated molecular dynamics
Othman, H., Ben Messaoud, H., Khamessi, O., Ben Mabrouk, H., Ghedira, K., Bharuthram, A., Treurnicht, F., Achilonu, I., Sayed, Y., Srairi-Abid, N.
10.1101/2021.05.24.445335 — Posted: 2021-05-24
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
Khan, W. H., Khan, N., Mishra, A., Gupta, S., Bansode, V., Mehta, D., Bhambure, R., Rathore, A. S.
10.1101/2021.05.23.445305 — Posted: 2021-05-24
Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning.
Hossain, M. S., Pathan, A. Q. M. S. U., Islam, M. N., Tonmoy, M. I. Q., Rakib, M. I., Munim, M. A., Saha, O., Fariha, A., Al Reza, H., Roy, M., Bahadur, N. M., Rahaman, M. M.
10.1101/2021.05.23.445341 — Posted: 2021-05-24
Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh
Nahid, A. A., Ghosh, A.
10.1101/2021.05.24.444482 — Posted: 2021-05-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).